Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
StrokeMuscle Spasticity
Interventions
BIOLOGICAL

Botulinum Toxin Type A

200 U to 360 U of botulinum toxin Type A on Day 0. Patients who met retreatment criteria received a second treatment (open-label) at Week 12 or Week 18

BIOLOGICAL

Placebo

Saline injection on Day 0

Trial Locations (1)

Unknown

Indianapolis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY